Can synergistic combinations rejuvenate existing antibiotics in the fight against antibiotic resistance?

Struggling with process research and development? Find yourself a CRO that knows what it’s doing.

The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.

Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.

The Chinese pharmaceutical market is already more advanced than many in the West imagine – and it only looks set to go in one direction.

Sam Herbert walks us through the past 50 years of pharma logistics.

Qualitative risk assessments are a great way to approach quality management and train your operators at the same time.

Microfluidics technology has room for improvement, but can undoubtedly impact protein analysis.

Drug repurposing is in vogue, but it’s not always as easy as you think.

Pharma manufacturers are not embracing patient-centric design when it comes to formulation. We need to go beyond tablets and capsules.